<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        211-212-06
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2006
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        DIAMET 250-1.25MG TABLETS
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        GLIBENCLAMIDE, METFORMIN HYDROCHLORIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        1.25, 250
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        8.75
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="SPIMACO" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            SPIMACO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 488]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            SPIMACO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            SPIMACO ADDWAEIH
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        A10BD02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Diamet is </strong>a combination product that contains two active ingredients, metformine hydrochloride and glibenclamide.</p><p>&nbsp;Metformin hydrochloride belongs to the groups of medicines called biguanide. It lowers your blood glucose by helping your body make better use of insulin.</p><p>Glibenclamide belongs to the groups of medicines called sulphonylurea. It lowers blood glucose by increasing the amount of insulin produced by your pancreas.</p><p><strong>Diamet is used </strong>to control blood glucose levels (the amount of sugar in the blood) in adults with type 2 diabetes mellitus. This type of diabetes known as non-insulin dependent diabetes (NIDDM) or maturity onset diabetes.</p><p><strong>Diamet is used:</strong></p><p>●&nbsp;&nbsp;&nbsp;&nbsp; When diet, exercise and treatment with either metformine or sulfonylurea medicine are not enough to control your blood glucose levels.</p><p>●&nbsp;&nbsp;&nbsp;&nbsp; As a replacement to metformine hydrochloride and glibeclamide when given separately to patients whose blood sugar levels are already well controlled and stable on such combination.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Diamet</strong></p><p>&middot; If you are allergic (hypersensitive) to metformin hydrochloride, glibenclamide or other</p><p>sulphonamides or any of the other ingredients of <strong>Diamet</strong></p><p>&middot; If you have kidney or liver function problems</p><p>&middot; If you suffer from type 1 diabetes mellitus (i.e. insulin-dependent) or if you have severe loss of diabetes control with either pre-coma or ketosis (a condition caused by substances called &lsquo;ketone bodies&rsquo; accumulating in the blood; you may notice that your breath has an unusual, fruity odor)</p><p>&middot; If you have a severe infection (for example an infection of the air passages or an urinary tract infection)</p><p>&middot; If you are dehydrated (for example due to persistent or severe diarrhea, recurrent vomiting)</p><p>&middot; If you are treated for heart problems, have recently had a heart attack, have severe circulatory problems or breathing difficulties</p><p>&middot; If you suffer from porphyria (a rare, hereditary disease due to an enzyme deficiency causing the body to produce and excrete too much porphyrin, a component used to make the part of blood pigment that carries oxygen)</p><p>&middot; If you use miconazole (a medicine to treat certain yeast infections) even for local use</p><p>&middot; If you drink alcohol excessively (either every day or only from time to time)</p><p>&middot; If you are breast-feeding.</p><p><strong>Make sure you ask your doctor for advice,</strong></p><p>&middot; If you need to have an examination such as X-ray or scan involving the injection of contrast medicines that contain iodine into your bloodstream</p><p>&middot; If you need to have a surgery under general, spinal or peridural anaesthesia</p><p>You must stop taking <strong>Diamet</strong> for a certain period of time before and after the examination or the surgery.</p><p>Your doctor will decide whether you need any other treatment for this time. It is important that you follow your doctor&rsquo;s instructions precisely.</p><p><strong>Take special care with Diamet</strong></p><p>&middot; If you experience symptoms of a condition called lactic acidosis, i.e. vomiting, bellyache with muscle cramps and a general feeling of discomfort with severe fatigue and difficulty in breathing (see section 4, &ldquo;Very rare side-effects&rdquo;).</p><p><strong>If these symptoms occur, STOP taking this</strong> <strong>medicine IMMEDIATELY and TELL your DOCTOR straight away.</strong></p><p>&middot; If you experience symptoms of low blood sugar (hypoglycemia).</p><p>The warning signs may occur suddenly and can include cold sweat, cold and pale skin, dizziness, headache, rapid heartbeat, feeling sick, feeling very hungry, temporary changes in vision, drowsiness, unusual tiredness and weakness, nervousness or tremor, feeling anxious, feeling confused, difficulty in concentrating.</p><p>If you notice any of these signs:</p><p>- First eat glucose tablets or a high sugar snack (honey, sweets, biscuits, fruit juice),</p><p>- <strong>STOP taking this medicine IMMEDIATELY and TELL your DOCTOR straight</strong></p><p><strong>away </strong>as you may need to be hospitalized to bring your blood glucose back under control,</p><p>- then rest.</p><p>General advice: Inform your family, friends and colleagues to turn you on your side and get medical aid straight away if you become unconscious. They should not give you any food or drink when you are unconscious. It could choke you.</p><p>A low blood sugar level might occur if:</p><p>- You eat too little or miss a meal</p><p>- Your diet contains insufficient or unbalanced levels of sugar</p><p>- You drink alcohol</p><p>- You exercise more than usual</p><p>- You have liver, kidney or certain hormone problems</p><p>- The dosage of your medicine is too high</p><p>- You are an elderly person</p><p>- You are taking certain medicines and <strong>Diamet</strong> at the same time (see section 2, &ldquo;Taking</p><p>other medicines&rdquo;).</p><p>Discuss with your doctor whether <strong>Diamet</strong> is the appropriate treatment for your diabetes if</p><p>you often experience severe symptoms of low blood sugar or if you find it hard to recognize them.</p><p>&middot; If you suffer from any infectious illnesses such as flu, infection of the air passages or urinary tract infection.</p><p>&middot; If you have an inherited condition where your red blood cells don&rsquo;t produce enough of the enzyme G6PD (G6PD deficiency), taking <strong>Diamet</strong> may cause your red blood cells to be destroyed too quickly (hemolytic anemia). Tell your doctor if you have this condition, as <strong>Diamet</strong> may not be suitable for you.</p><p>&middot; Continue to follow any dietary advice your doctor has given you and get some regular exercise while you are taking this medicine.</p><p>&middot; Consult your doctor regularly to test your blood sugar levels and your kidney function.</p><p>Consult your doctor, if any of the above-mentioned situations applies to you and if you feel unsure about using this medicine.</p><p><strong>Taking other medicines</strong></p><p><em>While taking </em><strong>Diamet</strong><em>, you must not use any of the following medicines:</em></p><p>&middot; Miconazole even for local use (see section 2, &ldquo;Do not take <strong>Diamet</strong>&rdquo;)</p><p>&middot; Iodinated contrast agents (see section 2, &ldquo;Do not take <strong>Diamet</strong>&rdquo;)</p><p><em>Special precautions may be required if you take </em><strong>Diamet</strong><em> and any of the following medicines at the same time:</em></p><p>&middot; Angiotensin-converting enzyme inhibitors (used to treat a variety of cardiovascular conditions, such as high blood pressure, and some other diseases)</p><p>&middot; Diuretics (used to remove water from the body by increasing urine production)</p><p>&middot; Beta-blockers (used to treat a variety of cardiovascular conditions, such as high blood pressure, and some other diseases)</p><p>&middot; Beta-2 agonists (used to treat asthma, such as ritodrine, salbutamol or terbutaline)</p><p>&middot; Bosentan (used to treat pulmonary hypertension)</p><p>&middot; Corticosteroids and tetracosactide (a class of hormones used to treat a variety of conditions, e.g. severe inflammation of the skin or in asthma)</p><p>&middot; Certain painkillers (i.e. non-steroidal anti-inflammatory drugs, such as phenylbutazone)</p><p>&middot; Fluconazole (used to treat certain yeast infections)</p><p>&middot; Chlorpromazine (a neuroleptic medicine, which affects how your brain works)</p><p>&middot; Desmopressin (generally used to reduce urine production)</p><p>&middot; Danazol (used to treat endometriosis, a condition where the tissue lining of the uterus is found outside the uterus)</p><p>Special precautions may include self-monitoring of blood glucose, blood tests and modification of dosage.</p><p>Avoid medicines containing alcohol (see section 2 &ldquo;Taking <strong>Diamet</strong> with food and drink&rdquo;).</p><p>Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.</p><p><strong>Taking Diamet with food and drink</strong></p><p>Avoid alcohol when you take this medicine as alcohol can increase certain side-effects such as lactic acidosis and a low blood sugar level (see section 4 &ldquo;Possible side-effects&rdquo;). This also applies to medicines containing alcohol.</p><p><strong>Pregnancy</strong></p><p>Tell your doctor if you are, you think you might be or are planning to become pregnant. During pregnancy, diabetes should be treated with insulin. If you find out that you are pregnant while taking <strong>Diamet</strong>, consult your doctor so that he/she may change your treatment.</p><p><strong>Breast-feeding</strong></p><p>You must not take <strong>Diamet</strong>, if you are breast-feeding or if you are planning to breast-feed your baby.</p><p><strong>Driving and using machines</strong></p><p>Do not drive or use machines:</p><p>&middot; If your vision is blurred. This may happen at the beginning of the treatment because of a lower level of sugar in your blood.</p><p>&middot; If you feel that symptoms of low blood sugar begin to appear.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Dosage</strong></p><p>Always take <strong>Diamet</strong> exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.</p><p>Only adults may take this medicine.</p><p>Your doctor will adapt the dosage of your treatment depending on its effect on your blood tests.</p><p>Continue to follow any dietary advice your doctor has given you. <strong>Diamet</strong> cannot replace the benefits of a healthy lifestyle.</p><p>Have a regular meal schedule with a sufficient and balanced sugar intake. This will decrease the risk of low blood sugar.</p><p>The usual starting dose is equivalent to the individual doses of metformin hydrochloride and glibenclamide you received before being treated with <strong>Diamet</strong>.</p><p>Maximum daily dose for <strong>Diamet</strong> 500 mg/5 mg: 6 tablets.</p><p><strong>Dosage adjustment in elderly patients</strong></p><p>Take special care if you are an elderly person. The dose of <strong>Diamet</strong> will be carefully increased depending on your blood sugar levels and your kidney function. Make sure that you consult your doctor regularly.</p><p><strong>Administration</strong></p><p>Take the tablets with a meal. Swallow each tablet whole with a glass of water. Do not crush or chew them before swallowing.</p><p>Take the tablets</p><p>&middot; Once a day, in the morning (breakfast) if you take 1 tablet per day</p><p>&middot; Twice a day, in the morning (breakfast) and evening (dinner) if you take 2 per day</p><p>&middot; Three times a day, in the morning (breakfast), noon (lunch) and evening (dinner), if you take 3, tablets per day.</p><p><strong>If you take more Diamet than you should</strong></p><p>If you have taken more <strong>Diamet</strong> tablets than you should have, you may experience lactic acidosis or low blood sugar (for symptoms of lactic acidosis and low blood sugar, see section 2, &ldquo;Take special care with <strong>Diamet</strong>&rdquo;).TALK to your DOCTOR IMMEDIATELY.</p><p><strong>If you forget to take Diamet</strong></p><p>Do not take a double dose to make up for a forgotten dose. Take the next dose at the usual time.</p><p><strong>If you stop taking Diamet</strong></p><p>There are usually no side effects when you stop taking this medicine. However, as your diabetes is not treated any more, complications due to a lack of treatment can occur.</p><p>If you have any further questions on the use of this product, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, <strong>Diamet</strong> can cause side effects, although not everybody gets them. The following side effects were observed in clinical studies or in routine patient management.</p><p>Vision disorders: When you start taking this medicine, it may disturb your vision due to a lower level of sugar in your blood. However, this reaction usually disappears after a while.</p><p>Low blood sugar: For symptoms of low blood sugar, see section 2, &ldquo;Take special care with <strong>Diamet</strong>&rdquo;.</p><p><strong>Very common side effects </strong>(in more than 1 in 10 patients)</p><p>&middot; Gastrointestinal disorders such as nausea, vomiting, diarrhea, bellyache and loss of appetite.</p><p>These side effects occur most frequently after starting therapy. It helps if you spread the doses over the day and if you take the tablets with a meal.</p><p>&nbsp;<strong>Should these symptoms continue, STOP</strong> <strong>taking this medicine and CONSULT your DOCTOR.</strong></p><p><strong>Common side effects </strong>(in less than 1 in 10, but more than 1 in 100 patients)</p><p>&middot; Taste disturbance</p><p><strong>Uncommon side effects </strong>(in less than 1 in 100, but more than 1 in 1,000 patients)</p><p>&middot; Abnormal urea and creatinine levels in the blood, which show changes in the way the kidneys are working.</p><p>&middot; A crisis of certain forms of porphyria (porphyria hepatica or porphyria cutanea; for an</p><p>explanation of porphyria, see section 2, &ldquo;Do not take <strong>Diamet</strong>&rdquo;) may occur in patients with certain enzyme deficiency.</p><p><strong>Rare side effects </strong>(in less than 1 in 1,000, but more than 1 in 10,000 patients)</p><p>&middot; Reduction in the number of white blood cells, which makes infections more likely</p><p>&middot; Reduction in blood platelets which increases risk of bleeding or bruising</p><p>&middot; Skin reactions including itching, hives, and skin rash</p><p><strong>Very rare side effects </strong>(in less than 1 in 10,000 patients)</p><p>&middot; Lactic acidosis: a very serious complication particularly if your kidneys are not working properly, which results in vomiting, bellyache with muscle cramps and a general feeling of discomfort with severe fatigue and difficulty in breathing and which requires specific treatment.</p><p><strong>If these symptoms occur, STOP taking this medicine IMMEDIATELY and TELL your DOCTOR straight away.</strong></p><p>&middot; Severe reduction in the number of white blood cells (agranulocytosis), anemia due to a too extensive breakdown of the red blood cells (hemolytic anemia), lack or insufficient number of new blood cells produced by the bone marrow (bone marrow aplasia) and very severe reduction in the number of blood cells (pancytopenia; this can make the skin look pale, can cause weakness or breathlessness, can increase the risk of bleeding or bruising or make infections more likely)</p><p>&middot; Abnormalities in liver function tests or inflammation of the liver (hepatitis; this can cause tiredness, loss of appetite, weight loss, with or without yellowing of the skin or whites of the eyes). In this case <strong>Diamet</strong> must be discontinued.</p><p>&middot; Excessive skin sensitivity to sun, serious allergic reactions of the skin or blood vessels</p><p>&middot; Intolerance to alcohol (with symptoms such as general feeling of discomfort, redness of face, rapid heartbeat).</p><p>&middot; Low level of sodium, which can cause tiredness and confusion, muscle twitching, fits or coma.</p><p>&middot; Decreased vitamin B12 levels in the blood</p><p>If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep out of the reach and sight of children.</p><p>Do not use <strong>Diamet</strong> after the expiry date, which is stated on the carton after &ldquo;EXP&rdquo;.</p><p>Store below 30&deg;C.</p><p>This medicinal product does not require any special storage conditions.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&middot; The active substances are metformin hydrochloride and glibenclamide.</p><p>&middot; One tablet of <strong>Diamet 250mg/1.25mg </strong>contains 250 mg of metformin hydrochloride</p><p>and 1.25 mg of glibenclamide</p><p>&middot; One tablet of <strong>Diamet 500mg/2.5mg </strong>contains 500 mg of metformin hydrochloride</p><p>and 2.5 mg of glibenclamide</p><p>&middot; One tablet of <strong>Diamet 500mg/5mg </strong>contains 500 mg of metformin hydrochloride</p><p>and 5 mg of glibenclamide</p><p>&middot; The other ingredients are: Avicel PH 101, povidone K 90, croscarmellose sodium Type A, magnesium stearate.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Diamet 500/5mg Tablets: A white to off-white, oblong, biconvex uncoated tablet, engraved with “222” on one side and plain on the other side.
Diamet 500/2.5mg Tablets: A white to off-white, oblong, biconvex uncoated tablet, engraved with “221” on one side and plain on the other side.
Diamet 250/1.25mg Tablets: A white to off-white, oblong, biconvex uncoated tablet, engraved with “169” on one side and plain on the other side.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>SPIMACO</strong></p><p>AlQassim pharmaceutical plant</p><p>Saudi Pharmaceutical Industries &amp;</p><p>Medical Appliance Corporation</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                July 2012.  
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>دياميت هو دواء يتكون من مداتين فعالتين هما: ميتفورمين هيدروكلوريد و&nbsp; جليبنكلاميد .</p><p>ميتفورمين هيدروكلوريد ينتمى إلى مجموعة من الأدوية والتى تعرف باسم بايجوانيد. تقوم هذه المادة بتخفيض مستوى السكر في الدم عن طريق تحسين استخدام جسمك للأنسولين.</p><p>جليبنكلاميد ينتمى إلى مجموعة من الأدوية والتى تعرف بمجموعة سلفونيل يوريا.&nbsp; تقوم هذه المادة بتخفيض مستوى السكر في الدم عن طريق تحفيز انتاج الأنسولين في البنكرياس.</p><p>يستخدم دياميت في خفض نسبة سكر الجلوكوز في الدم في حالة المرضى الذين يعانون من مرض السكري من النوع 2 (أى مرض السكر الغير معتمد على الإنسولين) الذي يسمى أيضا سكري البالغين.</p><p>استخدامات دياميت:</p><p>●&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عندما تكون الحمية، ممارسة الرياضة والعلاج بميتفورمين لوحده أو بدواء من مجموعة سلفونيل يوريا لوحده غير كاف للتحكم بمستويات سكر الجلوكوز في الدم.</p><p>●&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ليحل محل استخدام المادتين الفعالتين جليبنكلاميد و ميتفورمين هيدروكلوريد كل على حدة من قبل المرضى المعالجين بكلتا المادتين الفعالتين من قبل، إذا كانتا فعالتين في التحكم فى مستوى السكر بالدم لديهم.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>امتنع عن تناول أقراص دياميت وأخبر طبيبك فى الحالات الآتية:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من فرط التحسس لمادة ميتفورمين هيدروكلوريد، جليبنكلاميد أو أى من السلفوناميدات الأخرى أو أى من المكونات الأخرى لأقراص دياميت.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مصابا بمشاكل فى وظائف الكلية أو الكبد.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مرض السكر من النوع الأول (أى المعتمد على الإنسولين) أو إذا كنت تعانى من فقد شديد للسيطرة على مرض السكر يتمثل فى مرحلة ما قبل الغيبوبة أو الكيتوزية (وهى حالة تحدث بسبب مواد تسمى &quot;أجسام كيتونية&quot; تتراكم فى الدم، قد تلاحظ معها أن رائحة نفسك أصبحت مثل رائحة الفاكهة على غير العادة).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مصابا بعدوى حادة (على سبيل المثال وجود عدوى في مجرى الهواء العلوي أو التهاب المسالك البولية).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مصابا بالجفاف (على سبيل المثال نتيجة لإسهال مستمر أو شديد أو قئ متكرر).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تخضع للعلاج من مشاكل بالقلب، تعرضت لأزمة قلبية مؤخرا، لديك مشاكل شديدة في الدورة الدموية أو صعوبات في التنفس.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من بورفيريا (وهو مرض وراثى نادر الحدوث يحدث نتيجة نقص إنزيم مما يتسبب فى إفراز الجسم لكمية كبيرة من بورفيرين, وهو أحد المكونات المستخدمة في صنع جزء من صبغة الدم الذي يحمل الأكسجين).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تستخدم ميكونازول (وهو دواء لعلاج بعض أنواع عدوى الفطور السكرية) حتى ولو مع الاستخدام الموضعى.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تتناول الكحول بشكل مفرط (إما كل يوم أو فقط من وقت لآخر).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تقومين بالإرضاع طبيعيا.</p><p>تأكد من أن تسأل طبيبك للحصول على النصيحة فى الحالات الآتية:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت في حاجة الى فحص مثل الأشعة السينية أو المسح الضوئي التي تشمل حقن أدوية التباين التي تحتوي على اليود في مجرى الدم<strong>.</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تحتاج إلى أن تخضع لعملية جراحية تحت تأثير تخدير عام, تخدير نخاعي أو تخدير حول الجافية.</p><p>يجب أن تتوقف عن تناول دياميت لفترة معينة من الوقت قبل وبعد إجراء الفحص أو الجراحة.</p><p>وسوف يقوم الطبيب بتقرير ما إذا كنت تحتاج إلى علاج آخر خلال تلك الفترة. من الضرورى عليك أن تتبع تعليمات طبيبك المعالج بدقة.</p><p>ينبغى توخى الحذر عند تناول أقراص دياميت فى الحالات الآتية:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من أعراض حالة تسمى الحماض اللبني<strong>، </strong>بمعنى قئ<strong>, </strong>مغص<strong> </strong>مصحوب بتقلص فى العضلات والشعور العام بعدم الراحة مع التعب الشديد وصعوبة في التنفس (انظر الفقرة 4 &quot;أعراض جانبية نادرة جدا&quot;).</p><p>فى حالة حدوث هذه الأعراض امتنع عن تناول هذا الدواء فورا وقم بإخبار طبيبك المعالج مباشرة.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من أعراض انخفاض السكر في الدم (هيبوجلايسيميا).</p><p>علامات التحذير قد تحدث فجأة ويمكن أن تشمل عرق بارد، جلد بارد وشاحب، دوخة، صداع، سرعة ضربات القلب، غثيان، شعور بجوع شديد، تغيرات مؤقتة في الرؤية، نعاس وتعب غير معتاد و ضعف، عصبية أو رجفة، شعور بالقلق، شعور بالارتباك، صعوبة في التركيز.</p><p>إذا لاحظت أيا من هذه الأعراض:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أولا قم بتناول أقراص الجلوكوز أو وجبة غنية بالسكر (العسل، الحلويات، البسكويت، عصير الفاكهة).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; امتنع عن تناول هذا الدواء فورا وقم بإخبار طبيبك المعالج مباشرة فربما تحتاج إلى دخول المستشفى لاعادة الجلوكوز في الدم لديك تحت السيطرة.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ثم الراحة.</p><p>نصيحة عامة: أبلغ عائلتك وأصدقائك وزملائك لوضعك على جانبك والحصول على المعونة الطبية على الفور فى حالة فقدانك للوعى. يجب عليهم عدم إعطائك أى طعام أو شراب عندما تكون فاقدا للوعى. فقد يسبب لك الاختناق.</p><p>انخفاض مستوى السكر فى الدم قد يحدث فى الحالات الآتية:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تناول كمية قليلة جدا من الطعام أو تفويت وجبة.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; النظام الغذائي الخاص بك يحتوي على مستويات غير كافية أو غير متوازنة من السكر.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; شرب الكحول.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ممارسة التمارين الرياضية بشكل أكثر من المعتاد.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إصابتك بمشاكل بالكبد، الكلية أو مشاكل هرمونية.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; جرعة الدواء لديك مرتفعة جدا.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت شخصا مسنا.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تتناول أدوية معينة مع دياميت فى نفس الوقت (انظر الفقرة 2، &quot;تناول أدوية أخرى&quot;).</p><p>قم بمناقشة طبيبك المعالج حول ما إذا كان دياميت هو الدواء المناسب لعلاج مرض السكر لديك إذا<br />تعرضت في كثير من الأحيان لأعراض حادة من انخفاض السكر في الدم أو إذا كنت تجد صعوبة في التعرف عليها.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعانى من مرض معدى مثل الأنفلونزا، عدوى في مجرى الهواء أو التهاب المسالك البولية.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعانى من مرض وراثي حيث خلايا الدم الحمراء لديك لا تنتج ما يكفي من انزيم G6PD (نقص G6PD)، تناول أقراص دياميت قد يتسبب فى تدمير خلايا الدم الحمراء لديك بسرعة شديدة (هيموليتيك أنيميا). قم بإخبار طبيبك المعالج إذا كانت لديك هذه الحالة، إذ ربما يكون دياميت ليس العلاج المناسب لك.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كن حريصا على اتباع النصائح الغذائية الموصوفة لك من قبل طبيبك المعالج والقيام ببعض التمارين الرياضية المنتظمة وأنت تأخذ هذا الدواء.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; استشير طبيبك المعالج بانتظام لفحص مستوى السكر بالدم لديك ووظائف الكلية.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; استشير طبيبك المعالج، إذا كانت تنطبق عليك أى من الحالات المذكورة أعلاه أو إذا كنت تشعر بعدم الثقة حول استخدام هذا الدواء.</p><p>تناول أدوية أخرى</p><p>خلال فترة تناول دياميت، يجب عليك عدم استخدام أي من الأدوية التالية:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ميكونازول حتى ولو للاستخدام الموضعى (انظر الفقرة 2 &quot; ما يجب مراعاته قبل تناول أقراص دياميت&quot;).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أدوية التباين المحتوية على اليود (انظر الفقرة 2 &quot; ما يجب مراعاته قبل تناول أقراص دياميت&quot;).</p><p>قد يكون من الضرورى اتخاذ احتياطات خاصة عند تناول دياميت وأي من الأدوية التالية في نفس الوقت:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مثبطات الإنزيم المحول للأنجيوتنسين (والذى يستخدم لعلاج مجموعة متنوعة من حالات القلب والأوعية الدموية، مثل ارتفاع ضغط الدم، وبعض الأمراض الأخرى).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مدرات البول (والتي تستخدم لإزالة المياه من الجسم عن طريق زيادة إنتاج البول).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مثبطات بيتا (والتى تستخدم لعلاج مجموعة متنوعة من حالات القلب والأوعية الدموية، مثل ارتفاع ضغط الدم، وبعض الأمراض الأخرى).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; محفزات بيتا-2 (والتى تستخدم لعلاج الربو, مثل ريتودرين, سالبيوتامول أو تيربيوتالين).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بوزينتان (والذى يستخدم لعلاج ارتفاع ضغط الدم الرئوى).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الكورتيكوستيرويدات و تتراكوزاكتيد (فئة من الهرمونات لعلاج مجموعة متنوعة من الحالات، على سبيل المثال الالتهاب الحاد بالجلد أو فى حالات الربو).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بعض المسكنات (مثل مضادات الالتهابات غير الاستيرويدية، مثل فينيل بيوتازون).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فلوكونازول (الذى يستخدم لعلاج التهابات فطرية معينة).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كلوربرومازين (وهو دواء مضاد للذهان، والذي تؤثر على كيفية عمل الدماغ).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ديسموبريسين (وهو يستخدم بشكل عام لتقليل إفراز البول).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; دانازول (يستخدم لعلاج التهاب بطانة الرحم، وهي حالة يكون فيها النسيج المبطن للرحم موجود خارج الرحم).</p><p>الاحتياطات الخاصة قد تشتمل على الفحص الذاتى لمستوى السكر بالدم, اختبارات الدم وتعديل الجرعة.</p><p>تجنب تناول الأدوية التى تحتوى على الكحول (انظر الفقرة 4&quot; تناول دياميت مع الطعام والشراب&quot;).</p><p>يرجى إخبار الطبيب أو الصيدلي إذا كنت تتناول أو تناولت في الآونة الأخيرة أي أدوية أخرى، بما في ذلك الأدوية التي تم الحصول عليها دون وصفة طبية.</p><p>تناول دياميت مع الطعام والشراب</p><p>تجنب شرب الكحول عند تناول هذا الدواء حيث أن الكحول يمكن أن يتسبب فى زيادة بعض الآثار الجانبية مثل الحماض اللبني، وانخفاض مستوى السكر في الدم (انظر الفقرة 4 &quot; الآثار الجانبية محتملة الحدوث&quot;). ذلك أيضا ينطبق على الأدوية المحتوية على الكحول.</p><p>الحمل</p><p>فضلا أخبرى الطبيب إذا كنت حامل أو تعتقدين بأنك حامل أو تخططين لأن تصبحى حامل. خلال فترة الحمل يجب علاج مرض السكر باستخدام الإنسولين. لذلك يجب عليك فور اكتشافك للحمل إبلاغ الطبيب بذلك فقد يحتاج إلى تغيير العلاج الموصوف لك.</p><p>الرضاعة</p><p>يجب عليك عدم تناول أقراص دياميت، إذا كنت تقومين أو تنوى القيام بإرضاع طفلك طبيعيا.</p><p>القيادة واستخدام الآلات</p><p>لا تقم بقيادة السيارة أو استخدام الآلات فى الحالات الآتية:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعانى من عدم وضوح فى الرؤية. وقد يحدث هذا في بداية العلاج بسبب انخفاض مستوى السكر في الدم.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا شعرت ببداية ظهور أعراض انخفاض مستوى السكر فى الدم لديك.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>الجرعة</p><p>قم دائما بتناول أقراص دياميت تماما كما أخبرك الطبيب المعالج. إذا كنت غير واثق يجب عليك التحقق من خلال الطبيب أو الصيدلى.</p><p>هذا الدواء يتم تناوله من قبل البالغين فقط.</p><p>سوف يقوم طبيبك المعالج بتحديد الجرعة المناسبة لحالتك اعتمادا على تأثير الدواء على نتائج اختبارات الدم.</p><p>تأكد من استمرارك لاتباع النصائح الغذائية الموصوفة لك من قبل الطبيب. حيث أنه لا يستطيع دياميت أن يحل محل فوائد اتباع أسلوب حياة صحى.</p><p>يجب أن يكون لديك جدول زمني منتظم للوجبات يتضمن تناولك لكميات كافية ومتوازنة من السكر.</p><p>فسوف يقلل ذلك من خطورة الإصابة بانخفاض مستوى السكر بالدم.</p><p>جرعة البداية المعتادة تكون مكافئة لتلك الجرعات الفردية من ميتفورمين هيدروكلوريد وجليبنكلاميد والتى كنت تتناولها من قبل أن تخضع للعلاج بأقراص دياميت.</p><p>الجرعة اليومية القصوى من أقراص دياميت 500 ملجم/5 ملجم: هى 6 أقراص.</p><p>ضبط الجرعة في المرضى المسنين</p><p>يجب الحرص بشكل خاص إذا كنت شخصا مسنا. فسوف يتم زيادة جرعة دياميت بحرص اعتمادا على مستوى السكر بالدم ووظائف الكلى. تأكد من استشارة طبيبك المعالج بانتظام.</p><p>تناول الدواء</p><p>قم بتناول الأقراص مع الطعام. ابتلع القرص كاملا مع كوب من الماء. لا تقم بتكسير أو مضغ القرص قبل ابتلاعه.</p><p>قم بتناول الأقراص:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مرة واحدة يوميا، فى الصباح (مع الإفطار) إذا كنت تأخذ قرص واحد فى اليوم.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مرتين يوميا، صباحا (مع الإفطار) ومساء (مع العشاء) إذا كنت تأخذ قرصين فى اليوم.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ثلاث مرات يوميا، صباحا (مع الإفطار), ظهرا ( مع الغداء) ومساء (مع العشاء) إذا كنت تأخذ 3 أقراص يوميا.</p><p>إذا قمت بتناول أقراص دياميت أكثر مما ينبغى</p><p>إذا قمت بتناول أقراص دياميت أكثر مما ينبغى، فقد تتعرض للإصابة بالحماض اللبنى أو انخفاض مستوى السكر بالدم (لمعرفة أعراض الحماض اللبنى وانخفاض مستوى السكر بالدم انظر الفقرة 2&quot;ما يجب مراعاته قبل تناول أقراص دياميت&quot;). تواصل مع طبيبك المعالج فورا.</p><p>فى حالة نسيان تناول أقراص دياميت</p><p>لا تقم بتناول جرعة مضاعفة لتعويض الجرعة الفائتة. قم بتناول الجرعة القادمة فى الوقت المعتاد.</p><p>فى حالة التوقف عن تناول أقراص دياميت</p><p>عادة لا توجد آثار جانبية عند التوقف عن تناول هذا الدواء.</p><p>رغم ذلك، نتيجة لعدم علاج مرض السكر، قد يؤدى ذلك إلى حدوث مضاعفات سببها هو عدم وجود علاج لمرض السكر.</p><p>إذا كانت لديك أسئلة إضافية حول استخدام هذا الدواء، فضلا اسأل الطبيب أو الصيدلى.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل جميع الأدوية، دياميت قد يسبب آثار جانبية، وإن لم تكن تحدث لكل من يتناول هذا الدواء. الآثار الجانبية الآتية قد تمت ملاحظتها من خلال الدراسات السريرية أو من خلال التعامل الروتيني مع المرضى.</p><p>اضطرابات الرؤية: عندما تبدأ بتناول هذا الدواء، قد يسبب لك خلل فى الرؤية سببه هو انخفاض مستوى السكر بالدم. رغم ذلك سوف يزول هذا التأثير بعد فترة من الوقت.</p><p>انخفاض مستوى السكر بالدم: لمعرفة أعراض انخفاض مستوى السكر بالدم انظر الفقرة 2&quot; ما يجب مراعاته عند تناول أقراص دياميت&quot;.</p><p>آثار جانية شائعة جدا (تحدث لأكثر من واحد لكل 10 مرضى):</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات الجهاز الهضمي مثل الغثيان والتقيؤ، والمغص والاسهال وفقدان الشهية.</p><p>هذه الآثار الجانبية تحدث في معظم الأحيان بعد بدء العلاج. قد يساعدك على التخلص منها هو أن تنشر الجرعات على مدار اليوم، وأن تأخذ الأقراص مع وجبة الطعام.</p><p>فى حالة استمرار تلك الأعراض، توقف عن تناول هذا الدواء واستشير طبيبك المعالج.</p><p>آثار جانية شائعة (تحدث لأقل من واحد لكل 10 مرضى، ولكن أكثر من واحد لكل 100 مريض):</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطراب فى حاسة التذوق.</p><p>آثار جانية غير شائعة (تحدث لأقل من واحد لكل 100 مريض، ولكن أكثر من واحد لكل 1000 مريض):</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مستويات غير طبيعية من اليوريا والكرياتينين فى الدم، والتى توضح تغيرات فى وظائف الكلى.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أزمة بعض أشكال البورفيريا (البورفيريا الكبدية أو البورفيريا الجلدية، لتوضيح البورفيريا انظر الفقرة 2 &quot;لا تقم بتناول دياميت فى الحالات الآتية&quot;) والتى قد تحدث للمرضى المصابين بنقص إنزيم معين.</p><p>آثار جانية نادرة الحدوث (تحدث لأقل من واحد لكل 1000 مريض، ولكن أكثر من واحد لكل 10,000 مريض):</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض عدد خلايا الدم البيضاء والتى تجعل المريض أكثر عرضة للعدوى.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض عدد الصفائح الدموية مما يزيد من خطورة الإصابة بالنزيف أو الكدمات.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تفاعلات جلدية وتشمل الحكة، والشرى، والطفح الجلدي.</p><p>آثار جانية نادرة جدا (تحدث لأقل من واحد لكل 10,000 مريض):</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الحماض اللبنى: وهى حالة بالغة الخطورة خاصة ما إذا كانت الكلى لا تعمل بشكل صحيح، مما يؤدي إلى المغص، والتقيؤ مع تشنجات العضلات وشعور عام بعدم الارتياح مع التعب الشديد وصعوبة في التنفس والتي تتطلب معالجة خاصة.</p><p>فى حالة حدوث هذه الأعراض، توقف عن تناول هذا الدواء فورا وأخبر الطبيب مباشرة.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض حاد فى عدد خلايا الدم البيضاء (نقص الكريات المحببة)، أنيميا نتيجة التكسير الشديد لخلايا الدم الحمراء (فقر الدم الانحلالي)، نقص أو قلة عدد خلايا الدم الجديدة التي ينتجها النخاع العظمي (توقف نمو النخاع العظمى) والنقص الشديد جدا فى عدد خلايا الدم (فقر الدم اللاتنسجى: مما قد يسبب شحوب الجلد، وقد يتسبب فى الضعف أو ضيق في التنفس، وقد يزيد من خطورة الإصابة بالنزيف أو الكدمات أو يزيد من عرضة المريض للعدوى).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغيرات في اختبارات وظائف الكبد أو التهاب الكبد (الالتهاب الكبدى الوبائى، مما يسبب التعب، فقدان الشهية، نقص الوزن، مع أو بدون اصفرار الجلد أواصفرار بياض العينين). فى هذه الحالة يجب التوقف عن تناول أقراص دياميت.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حساسية الجلد المفرطة تجاه الشمس، مما يسبب تفاعلات تحسسية خطيرة فى الجلد أو الأوعية الدموية.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدم تحمل الكحول (مصحوبا بأعراض مثل الشعور العام بعدم الراحة، احمرار الوجه، وسرعة ضربات القلب).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض مستوى الصوديوم، والذي يمكن أن يسبب التعب والارتباك، وارتعاش العضلات، نوبات، أو غيبوبة.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نقص فيتامين ب12 بالدم.</p><p>إذا لاحظت أن أيا من هذه الآثار الجانبية أصبح جسيما،&nbsp; أو إذا لاحظت ظهور أى أعراض جانبية لم ترد فى هذه النشرة فإنه يرجى أن تخبر طبيبك المعالج أو الصيدلى الذى تتعامل معه بشأنها.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يحفظ الدواء بعيدا عن متناول ونظر الاطفال.</p><p>لا تستعمل أقراص دياميت بعد انتهاء تاريخ الصلاحية المدون على العبوة بعد EXP&rdquo;&quot;.</p><p>يحفظ في درجة حرارة أقل من 30 درجة مئوية.</p><p>لا يتطلب هذا الدواء أى ظروف خاصة للتخزين.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المواد الفعالة هى ميتفورمين هيدروكلوريد وجليبنكلاميد.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قرص واحد من دياميت 250 ملجم/1.25 ملجم يحتوى على 250 ملجم ميتفورمين هيدروكلوريد و 1.25 ملجم جليبنكلاميد.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قرص واحد من دياميت 500 ملجم/2.5ملجم يحتوى على 500 ملجم ميتفورمين هيدروكلوريد و 2.5ملجم جليبنكلاميد.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قرص واحد من دياميت 500 ملجم/5 ملجم يحتوى على 500 ملجم ميتفورمين هيدروكلوريد و 5 ملجم جليبنكلاميد.</p><p>&nbsp;</p><p>مكونات أخرى: افيسيل PH 101، بوفيدون K 90 ، كروسكرميلوز الصوديوم نوع&nbsp; A ، ستيارت المغنسيوم.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>دياميت 500/5 ملجم يتوافر على هيئة أقرص يتراوح لونها من اللون الأبيض إلى المائل للأبيض مستطيلة، محدبة الوجهين غير مغلفة، محفور على أحد الوجهين رقم 222 ، الوجه الآخر يخلو من أي كتابة. دياميت 500/2.5 ملجم يتوافر على هيئة أقرص يتراوح لونها من اللون الأبيض إلى المائل للأبيض مستطيلة، محدبة الوجهين غير مغلفة، محفور على أحد الوجهين رقم 221 ، الوجه الآخر يخلو من أي كتابة. دياميت 250/1.25 ملجم يتوافر على هيئة أقرص يتراوح لونها من اللون الأبيض إلى المائل للأبيض مستطيلة، محدبة الوجهين غير مغلفة، محفور على أحد الوجهين رقم 169 ، الوجه الآخر يخلو من أي كتابة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>مصنع الأدوية بالقصيم</p><p>الشركة السعودية للصناعات الدوائية والمستلزمات الطبية.</p><p>المملكة العربية السعودية</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            يوليو 2012.   
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                DIAMET 250 mg/12.2 mg, tablets 
DIAMET 500 mg/2.5 mg, tablets 
DIAMET 500 mg/5 mg, tablets 


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each tablet of Diamet 250mg/1.25mg contains 250 mg of glibenclamide and 1.25 mg of metformin hydrochloride
Each tablet of Diamet 500mg/2.5mg contains 500 mg of glibenclamide and 2.5 mg of metformin hydrochloride
Each tablet of Diamet 500mg/5mg contains 500 mg of glibenclamide and 5 mg of metformin hydrochloride
For a full list of excipients, see section 6.1. 

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Tablets 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Second line treatment of type 2 diabetes mellitus in adult patients whose glycaemic control is inadequate after diet and exercise alone, and where combined therapy is metformine and glibenclamide is appropriate.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Oral route.</p><p>For use in adults only.</p><p><strong>General: </strong></p><p>As for all hypoglycaemic agents, the dosage should be adapted according to the individual metabolic response (glycemia, HbA1c).</p><p><strong>Initiation of treatment: </strong></p><p>Treatment should be initiated with a dose of the combination product equivalent to previous individual doses of metformin and glibenclamide; the dose being gradually increased depending on results on glycemic parameters.</p><p><strong>Dose titration: </strong></p><p>The dosage should be adjusted every 2 weeks or longer, by increments of 1 tablet, depending on glycemia results.</p><p>A gradual increase in the dosage may aid gastrointestinal tolerance and prevent the onset of hypoglycemia.</p><p><strong>Maximum daily recommended dose: </strong></p><p>The maximum daily recommended dose is 6 tablets of Diamet 500 mg/2.5 mg.</p><p><strong>Dosage regimen: </strong></p><p>The dosage regimen depends on the individual posology:</p><p>&bull; Once a day, in the morning at breakfast, for a dosage of 1 tablet/day,</p><p>&bull; Twice a day, morning and evening, for a dosage of 2 or 4 tablets/day,</p><p>&bull; Three times a day, morning, noon and evening, for a dosage of 3, 5 or 6 tablets/day.</p><p>&nbsp;</p><p>The tablets should be taken with meals. The dosage regimen should be adjusted according to the individual eating habits. However, any intake must be followed by a meal with a sufficiently high carbohydrate content to prevent the onset of hypoglycemic episodes.</p><p><strong>Combination with insulin therapy: </strong></p><p>No clinical data are available on the concomitant use of this product with insulin therapy.</p><p><strong>Elderly subjects: </strong></p><p>The dosage of Diamet should be adjusted depending on renal function parameters (start with 1 tablet of Diamet 500 mg/2.5 mg); regular checks on the renal function are necessary (see section 4.4).</p><p><strong>Pediatric population: </strong></p><p>Diamet is not recommended for use in children (see section 5.1).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                • Hypersensitivity to metformin, glibenclamide or other sulphonylurea(s) and sulphonamides or to any of the excipients; 
• Type 1 diabetes (insulin-dependent diabetes), ketoacidosis, and diabetic pre-coma; 
• Renal failure or renal dysfunction (creatinine clearance < 60 ml/min); 
• Acute conditions with the potential to alter renal function such as: dehydration, severe infection, shock; 
• Acute or chronic disease which may cause tissue hypoxia such as cardiac or respiratory failure, recent myocardial infarction, shock; 
• Hepatic insufficiency, acute alcohol intoxication, alcoholism; 
• Porphyria; 
• Lactation; 
• In association with miconazole (see section 4.5).

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Lactic acidosis </strong></p><p>Lactic acidosis is a rare, but serious (high mortality in the absence of prompt treatment), metabolic complication that can occur due to metformin accumulation. Reported cases of lactic acidosis in patients on metformin have occurred primarily in diabetic patients with significant renal failure. The incidence of lactic acidosis can and should be reduced by assessing also other associated risk factors, such as poorly-controlled diabetes, ketosis, prolonged fasting, alcoholism, hepatic insufficiency and any condition associated with hypoxia.</p><p><em>Diagnosis: </em></p><p>The risk of lactic acidosis must be considered in the event of non-specific signs such as muscle cramps with digestive disorders as abdominal pain and severe asthenia.</p><p>This can be followed by acidotic dyspnea, abdominal pain, hypothermia and coma. Diagnostic laboratory findings are decreased blood pH, plasma lactate levels above 5 mmol/l, and an increased anion gap and lactate/pyruvate ratio. If metabolic acidosis is suspected, this medicinal product should be discontinued and the patient should be hospitalized immediately (see section 4.9).</p><p><strong>Hypoglycemia </strong></p><p>As it contains a sulphonylurea, Diamet exposes the patient to a risk of onset of hypoglycemic episodes. After treatment initiation, a progressive dose titration may prevent the onset of hypoglycemia. This treatment should only be prescribed if the patient adheres to a regular meal schedule (including breakfast). It is important that carbohydrate intake is regular since the risk of hypoglycemia is increased by a late meal, insufficient or unbalanced carbohydrate intakes. Hypoglycemia is more likely to occur in case of energy-restricted diet, after intensive or prolonged exercise, when alcohol intake or during the administration of a combination of hypoglycemic agents.</p><p><em>Diagnosis: </em></p><p>The symptoms of hypoglycemia are: headache, hunger, nausea, vomiting, extreme tiredness, sleep disorder, restlessness, aggression, impaired concentration and reactions, depression, confusion, speech impediment, visual disturbances, trembling, paralysis and paraesthesia, dizziness, delirium, convulsions, somnolence, unconsciousness, superficial breathing and bradycardia. Due to a counterregulation caused by the hypoglycemia sweating, fear, tachycardia, hypertension, palpitations, angina and arrhythmia can occur. These latter symptoms can be absent when the hypoglycemia is developed slowly, in case of autonomic neuropathy or when the patients take beta-blocking agents, clonidine, reserpine, guanethidine or other sympathomimetics.</p><p><em>Management of hypoglycemia: </em></p><p>Moderate hypoglycemic symptoms without loss of consciousness or neurological manifestations should be corrected by the immediate intake of sugar. An adjustment to the dosage and/or changes to meal patterns should be ensured. Severe hypoglycemic reactions with coma, seizures or other neurological signs are also possible and constitute a medical emergency requiring immediate treatment with intravenous glucose once the cause is diagnosed or suspected, prior to prompt hospitalization of the patient.</p><p>The careful selection of patients and dosage and adequate instructions for the patient are important to reduce the risk of hypoglycemic episodes. If the patient encounters repeated episodes of hypoglycemia, which are either severe or associated with unawareness of the situation, antidiabetic treatment options other than Diamet should be taken into consideration. Factors favoring hypoglycemia:</p><p>&bull; Concomitant administration of alcohol, especially combined with fasting,</p><p>&bull; Refusal or (more particularly in elderly patients) inability of the patient to co-operate,</p><p>&bull; Malnutrition, irregular meals, missed meals, fasting or changes to diet,</p><p>&bull; Poor balance between physical exercise and carbohydrate intake,</p><p>&bull; Renal failure,</p><p>&bull; Severe liver failure,</p><p>&bull; Overdose of Diamet,</p><p>&bull; Certain endocrine disturbances: thyroid insufficiency, pituitary and adrenal gland insufficiency,</p><p>&bull; Concomitant administration of certain other drugs (see section 4.5).</p><p><em>Renal and hepatic failure: </em></p><p>The pharmacokinetics and/or pharmacodynamics of Diamet may be modified in patients with hepatic failure or severe renal failure. If hypoglycemia occurs in such patients, it may be prolonged, and appropriate treatment must be initiated.</p><p><em>Patient Information: </em></p><p>The risks of hypoglycemia, its symptoms and its treatment, as well as its predisposing conditions, must be explained to the patient and his or her family. Similarly, the risk of lactic acidosis must be considered in the event of non-specific signs such as muscle cramps accompanied by digestive disorders, abdominal pain and severe asthenia, dyspnoea attributed to acidose, hypothermia and coma.</p><p>In particular, the patient should be informed of the importance of adhering to a diet, following a programme of regular physical exercise and making regular checks on glycemia.</p><p><strong>Blood sugar imbalance </strong></p><p>In case of surgery or any other cause of diabetic decompensation, temporary insulin therapy should be envisaged instead of this treatment.</p><p>The symptoms of hyperglycemia are: increased urinating, raging thirst and a dry skin.</p><p><strong>Kidney function </strong></p><p>As metformin is excreted by the kidney, creatinine clearance (this can be estimated from serum creatinine levels by using the Cockcroft-Gault formula) should be determined before initiating treatment and regularly thereafter:</p><p>&bull; At least annually in patients with normal renal function,</p><p>&bull; At least two to four times a year in patients with creatinine clearance at the lower limit of normal and in elderly subjects.</p><p>Decreased renal function in elderly subjects is frequent and asymptomatic. Special caution should be exercised in situations where renal function may become impaired, for example when initiating antihypertensive therapy or diuretic therapy, and when starting therapy with a non-steroidal anti-inflammatory drug (NSAID).</p><p><strong>Administration of iodinated contrast media </strong></p><p>The intravascular administration of iodinated contrast media in radiological studies can lead to renal failure. This may induce metformin accumulation and may expose to lactic acidosis. Depending on the renal function, Diamet must be discontinued 48 hours before the test or at the time of the test and may not be reinstituted until 48 hours afterwards, and only after renal function has been re-evaluated and found to be normal (see section 4.5).</p><p><strong>Concomitant use of glibenclamide with other medicinal products </strong></p><p>The concomitant use of glibenclamide with alcohol, phenylbutazone or danazol is not recommended (see section 4.5).</p><p><strong>Surgery </strong></p><p>Because Diamet contains metformin hydrochloride, Diamet must be discontinued 48 hours before elective surgery under general, spinal or peridural anesthesia and may not be reinstituted earlier than 48 hours following surgery or resumption of oral nutrition and only after renal function has been re-evaluated and found to be normal .</p><p><strong>Pancreatitis: </strong></p><p>Diamet must be discontinued when pancreatitis is combined with sepsis or hypoxia.</p><p><strong>Alcohol:</strong></p><p>Alcohol is known to potentiate the effect of metformine in lactate metabolism. Patients should be warned against excessive alcohol intake, acute or chronic, while taking Diamet, due to the increase of the risk of lactic acidosis particularly in case of fasting or malnutrition or hepatic insufficiency.</p><p><strong>Other precautions </strong></p><p>All patients should continue their diet, with a regular distribution of carbohydrate intake during the day. Overweight patients should continue their energy-restricted diet.</p><p>Regular physical exercise is as necessary as taking Diamet.</p><p>The usual laboratory tests for diabetes monitoring (glycemia, HbA1c) should be performed regularly,</p><p>Treatment of patients with G6PD-deficiency with sulphonylurea agents can lead to hemolytic anemia. Since glibenclamide belongs to the chemical class of sulphonylurea drugs, caution is recommended when using Diamet in patients with G6PD-deficiency and a non-sulphonylurea alternative may be considered.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Contraindicated combination </strong></p><p><u>Related to glibenclamide </u></p><p><em>Miconazole (systemic route, oromucosal gel): </em></p><p>Increase in the hypoglycemic effect with possible onset of hypoglycemic manifestations, or even coma (see section 4.3).</p><p><strong>Combinations not recommended </strong></p><p><u>Related to sulphonylurea(s) </u></p><p><em>Alcohol: </em></p><p>Antabuse effect (intolerance to alcohol), notably for chlorpropamide, glibenclamide, glipizide, tolbutamide.</p><p>Increase of the hypoglycemic reaction (inhibition of compensation reactions), which may facilitate the onset of a hypoglycemic coma (see section 4.4).</p><p>Avoid consumption of alcohol and alcohol-containing medications.</p><p><em>Phenylbutazone (systemic route): </em></p><p>Increase in the hypoglycemic effect of sulphonylurea(s) (displacement of sulphonylurea(s) from protein-binding sites and/or decrease in their elimination). Preferably use another anti-inflammatory agent exhibiting fewer interactions, or else warn the patient and step up self-monitoring; if necessary, adjust the dosage during treatment with the anti-inflammatory agent and after its withdrawal.</p><p><u>Related to all antidiabetic agents </u></p><p><em>Danazol: </em></p><p>If the combination cannot be avoided, warn the patient and step up self-monitoring of blood glucose. Possibly adjust the dosage of the antidiabetic treatment during treatment with danazol and after its withdrawal.</p><p><u>Related to metformin </u></p><p><em>Alcohol: </em></p><p>Acute alcoholic intoxication is associated with increased risk of lactic acidosis, particularly in cases of fasting (see section 4.4) or malnutrition and hepatocellular failure.</p><p>Avoid drinking alcoholic beverages and taking drugs that contain alcohol.</p><p><strong>Combinations requiring precautions </strong></p><p><u>Related to all antidiabetic agents </u></p><p><em>Chlorpromazine: </em></p><p>At high dosages (100 mg per day of chlorpromazine), elevation in blood glucose (reduction in release of insulin).</p><p>Precaution for use: warn the patient and step up self-monitoring of blood glucose. Possibly adjust the dosage of the antidiabetic treatment during treatment with the neuroleptic and after its withdrawal.</p><p><em>Corticosteroids (glucocorticoids) and tetracosactides (systemic and local routes):. </em></p><p>Elevation in blood glucose, sometimes accompanied by ketosis (decreased carbohydrate tolerance with corticosteroids).</p><p>Precaution for use: warn the patient and step up self-monitoring of blood glucose. Possibly adjust the dosage of the antidiabetic during treatment with corticosteroids and after their withdrawal.</p><p><em>&Beta;2-agonists: </em></p><p>Elevation in blood glucose due to the &beta;2-agonists.</p><p>Precaution for use: warn the patient, step up blood glucose monitoring and possibly transfer to insulin therapy.</p><p><em>Angiotensin converting enzyme inhibitors (e.g. captopril, enalapril): </em></p><p>ACE inhibitors may decrease the blood glucose levels. If necessary, adjust the dosage of Diamet during therapy with an ACE inhibitor and upon its discontinuation.</p><p><u>Related to metformin </u></p><p><em>Diuretics: </em></p><p>Lactic acidosis due to metformin triggered by any functional renal insufficiency, related to diuretics and more particularly to loop diuretics.</p><p><em>Iodinated contrast media: </em></p><p>Intravascular administration of iodinated contrast media may lead to renal failure. This may induce metformin accumulation and may expose to lactic acidosis. Depending on the renal function, Diamet must be discontinued 48 hours before the test or at the time of the test and not reinstituted until 48 hours afterwards, and only after renal function has been re-evaluated and found to be normal.</p><p><u>Related to glibenclamide </u></p><p><em>Beta-blockers: </em></p><p>All beta-blockers mask some of the symptoms of hypoglycemia : palpitations and tachycardia;</p><p>Most non-cardioselective beta-blockers increase the incidence and severity of hypoglycemia.</p><p>Warn the patient and step up blood glucose self-monitoring, especially at the start of treatment.</p><p><em>Fluconazole: </em></p><p>Increase in the half-life of sulphonylurea with possible onset of hypoglycemic manifestations.</p><p>Warn the patient and step up blood glucose self-monitoring, and possibly adjust the dosage of the antidiabetic treatment during treatment with fluconazole and after its withdrawal.</p><p><em>Bosentan: </em></p><p>Risk of decreased hypoglycemic effect of glibenclamide because bosentan reduces the plasma concentration of glibenclamide. An increased risk of liver enzyme elevations was reported in patients receiving glibenclamide concomitantly with bosentan.</p><p>Warn the patient, set-up monitoring of glycemia and liver enzymes and adjust the dosage of the antidiabetic treatment if necessary.</p><p><strong>Other interaction: combination to be taken into account: </strong></p><p><u>Related to glibenclamide </u></p><p><em>Desmopressin: </em></p><p>Reduction in antidiuretic activity.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pregnancy </strong></p><p>No preclinical and clinical data on exposed pregnancies are available for Diamet.</p><p><u>Risk related to diabetes </u></p><p>When uncontrolled, diabetes (gestational or permanent) gives rise to an increase in congenital abnormalities and perinatal mortality. Diabetes must be controlled as far as possible during the period of conception in order to reduce the risk of congenital abnormalities.</p><p><u>Risk related to metformin (see section 5.3) </u></p><p>Animal studies do not indicate harmful effects with respect to pregnancy, embryonic or fetal development, parturition or postnatal development.</p><p>A limited amount of data from the use of metformin in pregnant women does not indicate an increased risk of congenital abnormalities.</p><p><u>Risk related to glibenclamide (see section 5.3) </u></p><p>Studies in animals have shown no evidence of teratogenic activity. In the absence of a teratogenic effect in animals, fetal malformation in humans is not to be expected since to date, substances known to cause malformation in humans have proved to be teratogenic in well-conducted animal studies in two species.</p><p>In clinical practice, there are currently no relevant data on which to base an evaluation of potential malformation or fetotoxicity due to glibenclamide when administered during pregnancy.</p><p><u>Management </u></p><p>Adequate blood glucose control allows pregnancy to proceed normally in this category of patients. Diamet must not be used for the treatment of diabetes during pregnancy.</p><p>It is imperative that insulin be used to achieve adequate blood glucose control. It is recommended that the patient be transferred from oral antidiabetic therapy to insulin as soon as she plans to become pregnant or if pregnancy is exposed to this medicinal product. Neonatal blood glucose monitoring is recommended.</p><p><strong>Lactation </strong></p><p>Metformin is excreted into human breast milk. No adverse effects were observed in breastfed newborns/infants of mothers treated with metformin alone. However in humans, in the absence of data concerning passage of glibenclamide into breast milk, and in view of the risk of neonatal hypoglycemia, this medicinal product is contraindicated in the event of breast-feeding.</p><p><strong>Fertility </strong></p><p>Fertility of male or female rats was unaffected by metformin when administered at doses as high as 600 mg/kg/day, which is approximately three times the maximum recommended human daily dose based on body surface area comparisons.</p><p>Fertility of male or female rats was unaffected by glibenclamide when administered orally at dose of 100 and 300 mg/kg/day.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Patients should be alerted to the symptoms of hypoglycemia and should be advised to exercise caution when driving or using machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>During treatment initiation, the most common adverse reactions are nausea, vomiting, diarrhea, abdominal pain and loss of appetite which resolve spontaneously in most cases. To prevent them, it is recommended to take Diamet in 2 or 3 daily doses and to increase slowly the doses.</p><p>Transient visual disturbances may occur at the start of treatment due to a decrease in glycemia levels.</p><p>The following adverse reactions may occur under treatment with Diamet. Frequencies are defined as follows: very common: &ge;1/10; common &ge;1/100, &lt;1/10; uncommon: &ge;1/1,000, &lt;1/100; rare &ge;1/10,000, &lt;1/1,000; very rare &lt;1/10,000.</p><p><strong>Blood and lymphatic system disorders: </strong></p><p>These are reversible upon treatment discontinuation.</p><p><em>Rare</em>: Leucopenia, thrombocytopenia.</p><p><em>Very rare</em>: Agranulocytosis, hemolytic anemia, bone marrow aplasia and pancytopenia.</p><p><strong>Metabolism and nutrition disorders</strong>:</p><p>Hypoglycemia (see section 4.4).</p><p><em>Uncommon</em>: Crises of hepatic porphyria and porphyria cutanea.</p><p><em>Very rare</em>: Lactic acidosis (see section 4.4).</p><p>Decrease of vitamin B<sub>12</sub>absorption with decrease of serum levels during long-term use of metformin. Consideration of such etiology is recommended if a patient presents with megaloblastic anemia.</p><p>Disulfiram-like reaction with alcohol intake.</p><p><strong>Nervous system disorders: </strong></p><p><em>Common</em>: Taste disturbance.</p><p><strong>Eye disorders: </strong></p><p>Transient visual disturbances may occur at the start of treatment due to a decrease in glycemia levels.</p><p><strong>Gastrointestinal disorders: </strong></p><p><em>Very common</em>: Gastrointestinal disorders such as nausea, vomiting, diarrhea, abdominal pain and loss of appetite. These undesirable effects occur more frequently during treatment initiation and resolve spontaneously in most cases. To prevent them, it is recommended that Diamet be taken in 2 or 3 daily doses. A slow increase of the dose may also improve gastrointestinal tolerability.</p><p><strong>Skin and subcutaneous tissue disorders: </strong></p><p>A cross reactivity to sulphonamide(s) and their derivatives may occur.</p><p><em>Rare</em>: Skin reactions such as pruritus, urticaria, maculopapular rash.</p><p><em>Very rare</em>: Cutaneous or visceral allergic angiitis, erythema multiforme, exfoliative dermatitis, photosensitization, urticaria evolving to shock.</p><p><strong>Hepatobiliary disorders: </strong></p><p><em>Very rare</em>: Liver function test abnormalities or hepatitis requiring treatment discontinuation.</p><p><strong>Investigations: </strong></p><p><em>Uncommon</em>: Average to moderate elevations in serum urea and creatinine concentrations.</p><p><em>Very rare</em>: Hyponatremia.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Overdose may precipitate hypoglycemia due to the presence of the sulphonylurea (see section 4.4).</p><p>High overdose or the existence of concomitant risk factors may lead to lactic acidosis due to the presence of metformin (see section 4.4). Lactic acidosis is a medical emergency and must be treated in hospital. The most effective treatment is to remove lactate and metformin by haemodialysis.</p><p>The plasma clearance of glibenclamide may be prolonged in patients suffering from liver disease. Since glibenclamide is extensively bound to proteins, it is not eliminated by dialysis.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Biguanides and sulphonamide(s) in combination. ATC code: A10BD02</p><p>Metformin is a biguanide with antihyperglycaemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycemia.</p><p>Metformin may act via 3 mechanisms:</p><p>(1) By reducing hepatic glucose production by inhibiting gluconeogenesis and glycogenolysis</p><p>(2) In muscle, by increasing insulin sensitivity, improving peripheral glucose uptake and utilization</p><p>(3) And by delaying intestinal glucose absorption.</p><p>Metformin stimulates intracellular glycogen synthesis by acting on glycogen synthase. Metformin increases the transport capacity of all types of membrane glucose transporters (GLUT).</p><p>In humans, independently of its action on glycemia, metformin has favorable effects on lipid metabolism. This has been shown at therapeutic doses in controlled, medium-term or long-term clinical studies: metformin reduces total cholesterol, LDL-cholesterol and triglyceride levels. In clinical trials conducted so far with combination therapy with metformin and glibenclamide, these favorable effects on lipid metabolism have not been shown.</p><p>Glibenclamide is a second generation sulphonylurea with a medium half-life: it causes acute lowering of blood glucose by stimulating the release of insulin by the pancreas, this effect being dependent on the presence of functioning beta cells in the islets of Langerhans.</p><p>The stimulation of insulin secretion by glibenclamide in response to a meal is of major importance.</p><p>The administration of glibenclamide to diabetics induces an increase in the postprandial insulin-stimulating response. The increased postprandial responses in insulin and C-peptide secretion persist after at least 6 months of treatment.</p><p>Metformin and glibenclamide have different mechanisms and sites of action, but their action is complementary. Glibenclamide stimulates the pancreas to secrete insulin, while metformin reduces cell resistance to insulin by acting on peripheral (skeletal muscle) and hepatic sensitivity to insulin.</p><p>Results from controlled, double blind clinical trials versus reference products in the treatment of type 2 diabetes inadequately controlled by monotherapy with metformin or glibenclamide combined with diet and exercise, have demonstrated that the combination had an additive effect on glucose regulation.</p><p><strong>Pediatric population: </strong></p><p>In a 26-week, active controlled, double-blind, clinical study performed in 167 pediatric patients aged 9 to 16 years with type 2 diabetes not adequately controlled with diet and exercise, with or without an oral antidiabetic treatment, a fixed combination of metformin hydrochloride 250 mg and glibenclamide 1.25 mg was not shown more effective to either metformin hydrochloride or glibenclamide in reducing HbA1c from baseline. Therefore, Diamet should not be used in pediatric patients.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Related to the combination </strong></p><p>The bioavailability of metformin and glibenclamide in the combination is similar to that noted when one tablet of metformin and one tablet of glibenclamide are taken simultaneously. The bioavailability of metformin in the combination is unaffected by the ingestion of food. The bioavailability of glibenclamide in the combination is unaffected by the ingestion of food, but the absorption speed of glibenclamide is increased by eating.</p><p><strong>Related to metformin </strong></p><p><em>Absorption: </em></p><p>After an oral dose of metformin tablet, maximum plasma concentration (C<sub>max</sub>) is reached in approximately 2.5 hours (t<sub>max</sub>). Absolute bioavailability of a 500 mg or 850 mg metformin tablet is approximately 50-60% in healthy subjects. After an oral dose, the non-absorbed fraction recovered in feces was 20-30%.</p><p>After oral administration, metformin absorption is saturable and incomplete. It is assumed that the pharmacokinetics of metformin absorption is non-linear. At the usual metformin doses and dosing schedules, steady state plasma concentrations are reached within 24 to 48 hours and are generally less than 1 &mu;g/ml. In controlled clinical trials, maximum metformin plasma levels (C<sub>max</sub>) did not exceed 5 &mu;g/ml, even at maximum doses.</p><p><em>Distribution: </em></p><p>Plasma protein binding is negligible. Metformin partitions into erythrocytes. The blood peak is lower than the plasma peak and appears at approximately the same time. The red blood cells most likely represent a secondary compartment of distribution. The mean volume of distribution Vd ranged from 63 to 276 l.</p><p><em>Metabolism: </em></p><p>Metformin is excreted unchanged in the urine. No metabolites have been identified in humans.</p><p><em>Elimination: </em></p><p>Renal clearance of metformin is &gt; 400 ml/min, indicating that metformin is eliminated by glomerular filtration and tubular secretion. Following an oral dose, the apparent terminal elimination half-life is approximately 6.5 hours.</p><p>When renal function is impaired, renal clearance is decreased in proportion to that of creatinine and thus the elimination half-life is prolonged, leading to increased levels of metformin in plasma.</p><p><strong>Related to glibenclamide </strong></p><p><em>Absorption: </em></p><p>Glibenclamide is very readily absorbed (&gt; 95%) following oral administration. The peak plasma concentration is reached in about 4 hours.</p><p><em>Distribution: </em></p><p>Glibenclamide is extensively bound to plasma albumin (99%), which may account for certain drug interactions.</p><p><em>Metabolism: </em></p><p>Glibenclamide is completely metabolized in the liver to two metabolites. Hepatocellular failure decreases glibenclamide metabolism and appreciably slows down its excretion.</p><p><em>Excretion: </em></p><p>Glibenclamide is excreted in the form of metabolites via biliary route (60%) and urine (40%), elimination being complete within 45 to 72 hours. Its terminal elimination half-life is 4 to 11 hours.</p><p>Biliary excretion of the metabolites increases in cases of renal insufficiency, according to the severity of renal impairment until a creatinine clearance at 30 ml/min. Thus, glibenclamide elimination is unaffected by renal insufficiency as long as the creatinine clearance remains above 30 ml/min.</p><p><strong>Pediatric population </strong></p><p>There were no differences in pharmacokinetics of glibenclamide and metformin between pediatric patients and weight-and gender-matched healthy adults.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No preclinical studies have been performed on the combination product. Preclinical evaluation of the constituents metformin and glibenclamide revealed no special hazard for humans based on conventional studies of repeated dose toxicity, genotoxicity and carcinogenic potential.</p><p>Animal studies on metformin and glibenclamide do not indicate direct or indirect harmful effects with respect to pregnancy, embryonic/ fetal development, parturition or postnatal development. (see section 4.6).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Avicel PH 101</p><p>Povidone K 90</p><p>Croscarmellose Sodium Type A</p><p>Magnesium Stearate</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24Months/2Years 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C.</p><p>This medicinal product does not require any special storage conditions.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>30/pack</p><p>Clear PVC/PVDC Blister Strip and Aluminium Foil</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No Special Disposal<strong> </strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                SPIMACO
AlQassim pharmaceutical plant
Saudi Pharmaceutical Industries &
Medical Appliance Corporation

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                July 2012.
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>